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ABSTRACT
Efficient transcription of long polycistronic operons
in bacteria frequently relies on accessory proteins
but their molecular mechanisms remain obscure.
RfaH is a cellular elongation factor that acts as a
polarity suppressor by increasing RNA polymerase
(RNAP) processivity. In this work, we provide
evidence that RfaH acts by reducing transcriptional
pausing at certain positions rather than by accel-
erating RNAP at all sites. We show that ‘fast’ RNAP
variants are characterized by pause-free RNA chain
elongation and are resistant to RfaH action.
Similarly, the wild-type RNAP is insensitive to RfaH
in the absence of pauses. In contrast, those
enzymes that may be prone to falling into a
paused state are hypersensitive to RfaH. RfaH
inhibits pyrophosphorolysis of the nascent RNA
and reduces the apparent Michaelis–Menten
constant for nucleotides, suggesting that it stabi-
lizes the post-translocated, active RNAP state.
Given that the RfaH-binding site is located 75A ˚
away from the RNAP catalytic center, these results
strongly indicate that RfaH acts allosterically.
We argue that despite the apparent differences in
the nucleic acid targets, the time of recruitment
and the binding sites on RNAP, unrelated antitermi-
nators (such as RfaH and jQ) utilize common
strategies during both recruitment and anti-pausing
modification of the transcription complex.
INTRODUCTION
RNAP is an obligatory processive enzyme that must
complete synthesis of the entire RNA chain since the
transcripts that are released prematurely cannot re-enter
transcription cycle. In bacteria, even in the absence of the
tightly condensed chromatin, RNAP still encounters many
roadblocks that either stall it temporarily or trigger RNA
release. DNA-bound proteins, DNA lesions and various
nucleic acid signals that induce pausing, arrest and
termination (1) can hinder RNAP progression along the
template. Even at saturating substrate concentrations
in vitro, RNAP is moving in leaps, with its fast movement
along the template punctuated by pauses (2). Pausing
plays numerous regulatory roles, is an obligatory step
in termination pathways, and likely controls the overall
rate of RNA chain elongation (3).
RNAP is capable of making very long RNA chains
(30000nt long in bacteria) but its rate is rather modest
compared to DNA replicases: in Escherichia coli, elongat-
ing RNAP (a complex of a2bb0! subunits) moves at
20–90nt/s (4) whereas the replication fork advances
1000nt/s (5). This relatively ineﬃcient operation of
RNAP does not represent the limit of its catalytic
potential since ‘fast’ substitutions in the b and b0 subunits
that signiﬁcantly increase its overall rate in vitro have been
described (6–10). An attractive explanation rests on an
assumption that the relatively slow rate of transcription
is necessary for eﬃcient regulation of gene expression
where it provides for timely recruitment of, and response
to regulatory factors, attenuation control, as well as
determines folding pathways of the nascent RNA.
Moreover, in bacteria transcription and translation are
coupled, imposing additional restrictions on the speed that
RNAP can attain without placing the nascent RNA in
danger of release by Rho, which terminates the untrans-
lated messages (4). In other words, a catalytically perfect
RNAP would leave little room for regulation and likely
uncouple transcription and translation, while much
slower RNAP would not be nimble enough to keep up
with sustaining the RNA pool as it adapts to changing
environmental and physiological conditions. Indeed, while
diﬀerent ‘fast’ and ‘slow’ viable alleles of RNAP have been
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.
*To whom correspondence should be addressed. Tel: 614 292 6777; Fax: 614 292 8120; Email: artsimovitch.1@osu.edu
 2007 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.isolated, they alter the apparent elongation rate in vitro by
less than 3- to 5-fold in each direction (7,8,10–12), whereas
mutations coding for much faster or slower enzyme
variants are lethal (6,9,13–15).
As substitutions that constitutively change the overall
rate of RNA chain elongation appear to have a negative
impact on ﬁtness and are being removed by natural
selection, the stage is set for transient alteration of RNAP
kinetic properties by regulatory proteins. A subset of such
factors (known as antiterminators) reduces pausing and
termination (in other words, confers a fast phenotype)
thereby helping RNAP transcribe long operons. These
proteins use diﬀerent nucleic acid targets during recruit-
ment: lN binds the nascent RNA structure, lQi s
recruited to the double-stranded DNA near the promoter,
RfaH is recruited to the single-stranded non-template
(NT) DNA strand during elongation (16–19). The sites on
RNAP to which these proteins bind are likely also distinct:
we have recently concluded (20) that RfaH binds to the
b0-subunit clamp helices (b0 CH), whereas the target sites
for l regulators are still unknown but are thought to be
quite diﬀerent (21,22). Yet all antiterminators share
the ability to accelerate RNAP, suggesting that they
induce similar changes in the transcription elongation
complex (TEC).
To date, the changes that lead to the ‘antitermination’
modiﬁcation of the RNAP have not been characterized in
detail, and the molecular mechanism(s) by which elonga-
tion factors or substitutions in RNAP make the enzyme
faster or slower is not known: they may control nucleotide
addition at every template position by aﬀecting the
common rate-limiting step (which has not been elucidated
for RNAP), or inﬂuence the TEC isomerization into
oﬀ-pathway states at pause and termination sites (23).
We have proposed that at a pause site RNAP isomerizes
into a state in which nucleotide addition is slowed due to
transient changes in the active site architecture (Figure 1),
and from which diﬀerent classes of pause and termination
complexes arise (24). We further speculated that substitu-
tions in RNAP may alter its propensity towards the
isomerization into the slow state. In a fast RNAP,
the productive alignment of the 30 RNA end in the
active site, and consequently nucleotide addition, is
favored. In contrast, a slow RNAP is more likely to lose
the 30end from the active site and enter a paused state,
escape from which can be delayed by two orders of
magnitude. Antiterminators may act in the same regula-
tory pathway, switching RNAP into the fast state. Slow,
pause-prone enzymes should then be hypersensitive to
modiﬁcation by antiterminators, whereas fast RNAPs
should appear resistant to further acceleration.
To test this hypothesis, we have determined eﬀects of
the E. coli RfaH on RNA chain elongation by enzymes
from an expanded panel of fast and slow RNAPs, includ-
ing many previously uncharacterized kinetic variants.
RfaH is recruited to the TEC at speciﬁc sites (called ops)
and is required for expression of several long operons (25).
Reports from several labs indicated that RfaH acts as an
antiterminator both in vivo and in vitro (16), although the
exact mechanism of its action remains elusive. RfaH
structure and its binding site on the TEC are known (20).
RfaH increases the overall elongation rate in vitro,
reduces pausing at mechanistically distinct regulatory
sites (known as class I and II, Figure 1), and facilitates
bypass of some terminators (16,26). Unlike other well-
studied antiterminators (18,27), RfaH does not require
any accessory proteins (e.g. NusA or NusG), and its
action is not dramatically aﬀected by addition of the
cellular extract. These features allow us to dissect RfaH
eﬀect on the TEC in a highly puriﬁed model system.
Our results indicate that RfaH acts primarily to reduce
pausing: it fails to further accelerate the already fast
mutants, as well as the wild-type RNAP transcribing
under pause-free conditions, but is particularly eﬀective
with the enzymes that are prone to pausing because of
amino acid changes or substrate deprivation. In contrast,
RfaH cannot correct those slow phenotypes, which are
due to the defects in the elementary catalytic steps rather
than to the oﬀ-pathway events like pausing. We also show
that the enzymes traditionally regarded as fast are better
characterized as pause-resistant. We discuss our results




pIA238 encodes the wild-type rfaH ORF in pET28
(Novagen); the protein carries a His6 tag followed by
a thrombin cleavage site (16). pIA777 is a derivative of
Figure 1. Unactivated intermediate mechanism. During rapid elonga-
tion (top horizontal arrows) RNAP active site (represented by two
circles denoting the i and i 1 subsites) is optimized for facile catalysis:
the 30 OH of the nascent RNA is perfectly positioned to accommodate
the incoming substrate NTP. At some sites, the active site undergoes
a rearrangement to yield an unactivated intermediate in which the
nucleotide addition is slowed (paused state). The precise nature of this
rearrangement is unknown; it may include the 30 end fraying
(as shown), slight changes in the position of the catalytic residues or
Mg
2+ ion, etc. From the unactivated intermediate, RNAP can
isomerize into more stable, long-lived paused states upon the hairpin
formation (at class I sites) or backtracking (at class II sites), or into
a termination complex. Substitutions in RNAP that confer ‘fast’ and
‘slow’ elongation phenotypes (such as bP560S,T563I and bQ513P,
respectively) may aﬀect isomerization into the unactivated intermediate
by favoring diﬀerent states of the RNAP active site (24).
Nucleic Acids Research, 2007, Vol. 35, No. 17 5695pET36b(+) (Novagen) that encodes RfaH N-domain–
TEV–C-domain–[His6]. Plasmid pVS10 (20) encodes the
wild-type E. coli core RNAP. Other plasmids used
to purify RNAP variants were: pIA542, b0Y795A;
pIA627, b0T786V; pIA433, bH625Y; pIA434, bQ513P;
pVS48, b0F773V; pIA645, bD675A; pVS14,
b0[943-1130]; pIA639, b0S793F; pVS50,
b0L672D,V673D; pIA622, bS1105A; pIA648, bM1107A;
pIA780, b0 [282-292]Gly4. Sequences of all plasmid
constructs were veriﬁed at the OSU PMGF center and
will be made available upon request.
Proteins and reagents
All general reagents were obtained from Sigma and
Fisher; NTPs and [a
32P]-NTPs, from GE; PCR reagents,
restriction and modiﬁcation enzymes, from NEB. Oligo-
nucleotides were obtained from Integrated DNA Tech-
nologies. DNA puriﬁcation kits were from Qiagen and
Zymo Research. The full-length RfaH, RfaH N-domain,
and RNAPs were puriﬁed as described in (20).
bP560S,T563I RNAP was puriﬁed as described in (24).
Transcription elongation assays
For pause assay with RNAP variants and full-length
RfaH, linear DNA template generated by PCR ampliﬁca-
tion (30nM), holo RNAP (40nM), ApU (100mM), and
starting NTP subsets (1mM CTP, 5mM ATP and GTP,
10mCi [a
32P]-CTP, 3000Ci/mmol) were mixed in 100mlo f
20mM Tris–acetate, 20mM Na-acetate, 2mM Mg acet-
ate, 5% glycerol, 1mM DTT, 0.1mM EDTA, pH 7.9.
Reactions were incubated for 15min at 378C. RfaH was
added to 50nM where indicated (for 3min at 378C) and
transcription was restarted by addition of nucleotides
(10mM GTP, 150mM ATP, CTP and UTP) and rifapentin
to 100mg/ml at 378C. Samples were removed at 10, 20, 30,
40, 60, 90, 120, 180, 240, 360, 480, 600, 720s and after a
ﬁnal 5-min incubation with 200mM GTP, quenched by
addition of an equal volume of STOP buﬀer (10M urea,
20mM EDTA, 45mM Tris–borate; pH 8.3), and loaded
on 8% denaturing urea/acrylamide (19:1) gels in 0.5 
TBE. The gels were dried and analyzed using Storm 820
and ImageQuant (GE). Pause half-life (the time during
which half of the complexes re-enter the elongation
pathway) was determined by non-linear regression analy-
sis. Termination assays were performed as described in
(26). Assays with the N-domain of RfaH were performed
in 20mM Tris–HCl, 14mM MgCl2, 20mM NaCl, 5%
glycerol, 1mM DTT, 0.1mM EDTA as described in (20).
Pyrophosphorolysis
Linear pIA226 DNA template generated by PCR ampli-
ﬁcation (100nM), holo RNAP (120nM), ApU (100mM),
N-domain (120nM) (or storage buﬀer) and starting NTPs
(1mM GTP, 5mM ATP and UTP, 10mCi [a
32P]-GTP,
3000Ci/mmol) were mixed in 25ml of buﬀer TGC
2
(20mM Tris–Cl, 20mM NaCl, 2mM MgCl2, 5% glycerol,
1mM DTT, 0.1mM EDTA, pH 7.9), and incubated
for 15min at 378C. Halted A26 complexes were puriﬁed
by gel ﬁltration through AutSeq50 spin columns (GE)
equilibrated in TGC
2, and diluted 2-fold. Reactions were
initiated by the addition of 1/10 vol of 250mMP P i in
TGC




We ﬁrst tested RfaH eﬀect on two model enzymes,
the slow RpoB8 (bQ513P) and the fast RpoB5101
(bP560S,T563I), whose elongation, pausing and termina-
tion properties are well known (12,24): B8 pauses and
terminates more eﬃciently and elongates RNA less rapidly
than the wild-type RNAP, whereas B5101 displays the
opposite phenotypes. We ﬁrst employed the standard
single-round termination assay on Thly, a typical intrinsic
terminator from the hemolysin operon that responds to
RfaH in vivo (28) and in vitro (26), to test if these enzymes
diﬀer in their response to RfaH. We used the pIA416
linear transcription template on which the Thly was
positioned downstream from a strong T7A1 promoter
and a canonical ops element (Figure 2A). On this template,
radiolabeled transcription complexes can be halted at
position G37 when transcription is initiated in the
absence of UTP, with ApU dinucleotide, ATP, GTP and
a–[
32P]CTP. The halted G37 complexes can then be
chased upon addition of all four NTP substrates and
RfaH. We found that RfaH (at 50 nM) decreased
termination by the wild-type RNAP by  2-fold, but was
much more eﬀective with the slow RNAP ( 3-fold eﬀect),
and less eﬀective ( 1.4-fold eﬀect) with the fast variant
(Figure 2A).
The termination assay lends support to our hypothesis
but does not allow us to distinguish whether RfaH fails
to bind to the bP560S,T563I TEC or is unable to trigger
the post-recruitment RNAP modiﬁcation. We then used
the pIA349 template (16) that allows to monitor both
RfaH recruitment to the ops site and its post-recruitment
eﬀect at the his pause site (Figure 2B); this template is
identical to pIA416 except for the sequence downstream of
the ops element. The ops element induces RNAP pausing
at position 43 with nearly 100% eﬃciency in vitro; when
present, RfaH reduces pausing at U43 but dramatically
delays RNAP at a site located 2nt downstream (C45).
This characteristic delay at the C45 position can be used
to ascertain RfaH recruitment to the NT DNA. When
halted G37 complexes were formed with wild-type RNAP
and chased in the presence of RfaH, the half-life of the
hisP was reduced  2.7-fold (Figures 2B and 3A). This
eﬀect was independent of the source and method used
for RNAP puriﬁcation: the same results were obtained
with the chromosomally-encoded RNAP puriﬁed from
MRE600 cells by the standard procedure (16) or expressed
from the multi-cistronic vector and puriﬁed using chitin-
binding domain-intein tag on b0(6) or hexahistidine tag
on b0 (20) during the ﬁrst, aﬃnity puriﬁcation step.
When the wild-type RNAP was replaced by fast or slow
variants, RfaH failed to reduce pausing at the hisP site by
bP560S,T563I, and was particularly eﬀective with the
bQ513P enzyme (Figures 2B and 3A). Addition of RfaH
5696 Nucleic Acids Research, 2007, Vol. 35, No. 17produced the delay at C45 by all three enzymes, suggesting
that it was recruited to the TEC in a similar fashion.
We extended this analysis to include a panel of enzymes
that were obtained during previous studies of resistance to
antibiotics (13,14,29,30), analysis of species-speciﬁc diﬀer-
ences in response to regulatory signals (6) and the
mechanism of substrate selection (31); these RNAPs
displayed a range of elongation rates in vitro. All these
RNAPs were puriﬁed through several chromatographic
steps, and were free from accessory proteins. We excluded
from this analysis a number of enzymes with gross defects
in transcription, such as the very slow b0N458D (31) or
Figure 2. RfaH has diﬀerent eﬀects on the fast and slow RNAPs. (A) Single-round termination assay on pIA416 template encoding the
RfaH-responsive Thly terminator with the wild-type, slow (bQ513P) and fast (bP560S,T563I) RNAPs. Top. The relevant template features, start site
(+1), transcript end (run-oﬀ, RO), the ops pause site (opsP, U43) and Thly terminator, are indicated in the schematic shown on top. The termination
eﬃciency (TE) was determined as a ratio of terminated RNA (T) to the total RNA, the sum of the terminated and run-oﬀ products. A representative
assay is shown on the right. (B) Single-round pause assay on a linear pIA349 template (top). Halted radiolabeled G37 TECs were pre-incubated with
RfaH or storage buﬀer for 5min at 378C, and then challenged with rifapentin at 100mg/ml and NTPs (10mM GTP, 150mM ATP, CTP, UTP).
Aliquots were withdrawn at times ranging from 10 to 720s and after a high GTP chase and analyzed on 8% denaturing gels.
Nucleic Acids Research, 2007, Vol. 35, No. 17 5697b0R1106A (32). We used the rate of RNAP escape from
the hisP site (in the same assay system as in Figure 2B) to
evaluate the post-recruitment eﬀects of RfaH; RfaH also
reduces the his pause eﬃciency (16) but this parameter
is diﬃcult to measure accurately, particularly with the
slow RNAPs that pause at the upstream sites more
prominently, and thus arrive at the hisP site asynchro-
nously. We found that RfaH acted similarly on the wild-
type enzyme and a variant with the ‘wild-type’ overall
elongation rate (b0T786V) while failing to accelerate
the fast enzymes (bH526Y/RpoB2, bD675A, b0F773V,
b0SI3, and bP560S,T563I) to the same extent (the defects
varied, though). The slow enzymes fell into two categories:
four variants (b0S793F, b0Y795A, bQ513P, and
b0L672D,V673D) displayed augmented response, whereas
two others (bS1105A and bM1107A)—reduced response
to RfaH (Figure 3A). The summary of our ﬁndings is
presented in Figure 3B, where the positions of these
RNAP substitutions are shown in the context of the model
of RfaH bound to the TEC.
RfaH isstill recruited tofast RNAPs
The observation that RfaH cannot further accelerate
those RNAPs that are already fast is consistent with the
proposed switch. However, there remain two trivial
explanations: (i) the RfaH-binding site is altered by
substitutions or (ii) RfaH does not become recruited to
the fast elongation complexes because these TECs move
through the ops signal too rapidly.
Several observations argue against the ﬁrst possibility.
First, substitutions that confer fast phenotypes are located
in diﬀerent regions, far apart from each other, and in the
regions that are not accessible from the enzyme surface
in the context of the TEC (Figure 3B). Second, RfaH-
binding site is located on the tip of the b0 CH (20), 50A ˚
away from the closest fast substitution. Third, RfaH still
delays the fast enzymes immediately downstream from
the ops site (Figure 2B). Finally, RfaH aﬀects the kinetic
parameters of the fast enzymes (see subsequently).
In contrast, RNAPs with substitutions or deletions in
the b0CH possess ‘wild-type’ elongation properties but
are totally defective in both the recruitment of RfaH at the
ops site and the post-recruitment response to RfaH at
the downstream sites (20).
To exclude the second possibility, we utilized the
isolated N-terminal domain of RfaH in place of the full-
length protein. The N-domain contains all the DNA- and
RNAP-binding determinants and retains all the elonga-
tion enhancement properties of RfaH (20). However, it no
longer requires the ops site for binding to the TEC because
its RNAP-binding site is always exposed (see Discussion
section)—thus, the N-domain binds to (presumably) all
TECs formed by the wild-type RNAP (in particular,
the halted G37 in Figure 2B; data not shown) and has
ample opportunities to become recruited to the G37 TECs
formed by the fast enzymes, provided that the RfaH-
binding site remains intact. We found that the N-domain
accelerated the wild-type RNAP but not the two fastest
mutants, b0F773V and b0SI3 (Figure 4); however, the
N-domain was clearly recruited to the altered TEC since
Figure 3. The summary of the RfaH eﬀects on pausing at the hisP site
by the RNAP variants. (A). The data from experiments similar to those
shown in Figures 2B were analyzed as described in (20); for each
enzyme, the assay was repeated at least twice. The kp for escape from
the pause was measured in the presence and in the absence of RfaH;
the ratio is presented below each variant. The pause eﬃciency cannot
be determined reliably, particularly for the slow enzymes which display
signiﬁcant asynchrony during elongation. The substitutions that are
fast and resistant to RfaH are colored in red, those that displays the
wild-type elongation rate and response to RfaH are colored in blue, the
substitutions that are slow and hypersensitive to RfaH—in green.
Finally, the b S1105 and b M1107 residues, whose substitutions to Ala
both reduce the elongation rate and the response to RfaH, are shown in
orange. (B). A model of RfaH bound to the TEC. The Thermus
thermophilus RNAP (46) is shown in gray with the bridge helix
highlighted in magenta, the template DNA—in red, the NT DNA—in
black, the nascent RNA—in yellow. Position of the RNAP active site is
marked by the high-aﬃnity catalytic Mg
2+ ion (small magenta sphere).
RfaH (green) is bound to the b0 CH. The Ca atoms of the RNAP
substitutions tested in this work are shown as spheres and colored
according to their response to RfaH as in panel A. The disordered b0
trigger loop is depicted as a cyan dashed line, with the b0SI3 domain
(missing in T. thermophilus) inserted in the middle; the b0SI3 deletion
variant used here lacks E. coli b0 residues 943–1130 (6). The distance
between the RfaH contact site on the b0 CH and the nearest residue
shown (b Q513) is 53A ˚ .
5698 Nucleic Acids Research, 2007, Vol. 35, No. 17it delayed all three RNAPs at the C45 site similarly.
We conclude that RfaH binds to the fast RNAPs but fails
to accelerate them further.
RfaH doesnot accelerate RNAP in theabsence of pausing
If RfaH works as an anti-pausing factor, its failure to
accelerate the fast enzymes could be due to their inability
to pause. Indeed, all the templates that we have tested for
RfaH eﬀects on elongation thus far contained pause sites
(opsP and hisP), at which the wild-type RNAP pauses
with high eﬃciency, but the fast enzymes do not. A simple
prediction of this mechanism would be that if the
wild-type RNAP transcribed a template devoid of any
strong pauses, particularly at saturating concentrations of
substrate NTPs, it would also become resistant to RfaH
action because pausing would no longer determine the
overall elongation rate. Since the ops site is in itself a
pause, we utilized an ops-less template pIA146 (Figure 5A)
that encodes the rpoB gene fragment and the ops-
independent N-domain. While it is impossible to ﬁnd a
truly pause-less natural DNA template, the rpoB gene is
the best model system known: it is devoid of strong
regulatory pauses and has been used extensively in studies
of RNA chain elongation (2,33). We monitored the overall
elongation rate by accumulation of 1225nt run-oﬀ
RNA (Figure 5B). At 1mM NTPs, the N-domain failed
to accelerate wild-type RNAP, and the mean rate was
actually reduced from 30 to 25nt/s (Figure 5C). However,
wild-type RNAP was modestly (1.7-fold) accelerated by
the N-domain at subsaturating (25mM) NTPs. The net
eﬀect of the RfaH N-domain on wild-type RNAP
(Figure 5D) was the reduction in Km and, more
importantly, the 1.7-fold increase in the kcat/Km ratio
that approximates the second order rate constant for
substrate binding. The increase in the kcat/Km ratio was
more pronounced (2.1-fold) with the slow bQ513P RNAP,
which was accelerated by the RfaH N-domain even at
1mM NTPs; apparently this enzyme was still limited
by substrate availability under such conditions. Interest-
ingly, the fastest RNAPs in our collection, b0F773V and
b0 SI3, were actually slower than the wild type at
1mM NTPs, and were not accelerated by N-domain at
all NTPs concentrations tested (from 25mM to 1mM;
Figure 5D and data not shown). We conclude that the
fast phenotype of these enzymes is due to their inability to
pause rather than the higher intrinsic elongation rate.
Consequently, it appears that RfaH acts by reducing
pausing rather than by increasing the elongation rate, as it
fails to act under the conditions that already suppress
pausing.
Figure 4. The isolated N-domain of RfaH fails to accelerate the fast RNAPs. The assay was performed on pIA349 template (Figure 2B).
Nucleic Acids Research, 2007, Vol. 35, No. 17 5699RfaHinhibits pyrophosphorolysis
Molecular motions that underlie the formation of the
paused state are not known in detail, but this isomeriza-
tion likely occurs from the pre-translocated state and
involves some rearrangements of the active site (see
Discussion section). The increase in NTP concentration
is known to reduce pausing by shifting the TEC into the
post-translocated state. RfaH increases kcat/Km ratio,
thus eﬀectively mimicking the increase in the NTP
concentration, and may therefore also act to stabilize
the post-translocated state either directly or indirectly,
by increasing the TEC0s aﬃnity for substrate NTPs during
elongation. To distinguish between these possibilities,
we examined the eﬀect of RfaH on pyrophosphorolysis,
a reversal of the nucleotide addition reaction that occurs
in pre-translocated TEC (Figure 6A) in the absence
of NTPs.
We used halted A26 complexes that exist predominantly
in pre-translocated or even backtracked state and are
sensitive to PPi—or Gre-mediated transcript cleavage,
respectively (13). We formed halted radiolabeled A26
complexes in the absence or in the presence of the RfaH
N-domain, and then challenged these complexes with
low concentrations of PPi (25mM) for 10–180s at 378C
(Figure 6A); as reported previously, A26 complexes were
highly sensitive to cleavage, generating 25- and 24-mer
products within 10s.
We found that complexes formed with the wild-type
RNAP were stabilized against PPi-induced cleavage by
the N-domain (Figure 6C). This eﬀect was dependent on
speciﬁc RfaH–RNAP interaction because RNA cleavage
in the complexes formed with the b0 CH enzyme, which
lacks the RfaH contact site and is unable to respond to
either full-length RfaH or N-domain (20), was not altered
in the presence of the N-domain. The apparent protection
against pyrophosphorolysis is consistent with the hypoth-
esis that RfaH stabilizes the post-translocated state of the
TEC. These results are inconsistent with the direct eﬀect of
RfaH on NTP binding: if RfaH acted primarily to increase
the substrate aﬃnity, it would facilitate forward and
Figure 5. RfaH does not accelerate transcription in the absence of pausing. (A) The pIA146 template. (B) Halted radiolabeled A29 TECs formed
with the wild-type (WT) RNAP were extended with NTPs in the absence (upper panels) or in the presence (lower panels) of the RfaH N-domain,
aliquots were withdrawn at indicated times and analyzed on 4% denaturing gels. Only the gel region near the full-length transcript (RO) is shown.
(C) The mean elongation rate of the WT, bQ513P and b0SI3 RNAPs as a function of [NTPs] in the absence (circles) and the presence (squares)
of the RfaH N-domain. The mean rate was estimated by ﬁtting the RO product accumulation (data from panel B and analogous experiments)
to exponential (with an oﬀset) cumulative distribution function using Scientist 3.0 software (Micromath). (D) Michaelis–Menten parameters kcat, Km
and kcat/Km ratio estimated from data in C.
5700 Nucleic Acids Research, 2007, Vol. 35, No. 17reverse reactions similarly at limiting substrate concentra-
tions (such as used here) because RNAP contacts to
the b and g phosphates (pyrophosphate moiety) constitute
the major fraction of the NTP interactions in the
substrate-bound TEC (34). In summary, our data argue
that RfaH increases NTP binding indirectly by
favoring the particular (post-translocated) TEC confor-
mation that serves as a target for NTP, thereby facilitating
the catalysis in the forward (nucleotide addition)
direction.
DISCUSSION
In this work, we demonstrate that the response of
the E. coli RNAP to bacterial antiterminator RfaH is
modulated by the kinetic properties of the enzyme itself:
enzyme variants with the same or slower elongation
rate than the wild-type RNAP are accelerated by RfaH,
whereas the fast enzymes are resistant to its action. The
widely spread positions of the residues altered in
RfaH-resistant RNAPs (Figure 3B) and the fact that the
RfaH-binding target, the b0CH, is located 50 and 75A ˚
away from the closest substitution and the RNAP active
site, respectively, argue against a direct eﬀect of fast
substitutions on RfaH binding and in support of an
allosteric mechanism of control. Below we oﬀer structural
insights into the origins of the anti-pausing behavior of
RfaH. Our analysis also allows us to draw many parallels
to other antitermination systems—we compare the RfaH
mechanism of action to that of lQ to conclude that in
spite of the apparent diﬀerences in the nucleic acid targets,
the time of recruitment, and the targets on RNAP, the two
proteins share many details of the molecular mechanism
during both recruitment and post-recruitment modiﬁca-
tion of the TEC.
RfaHand fast substitutions increase TEC processivity
exclusively byreducing pausing
Our data demonstrate that the elongation enhancer RfaH
as well as fast and majority of slow substitutions modulate
the RNAP rate by altering its propensity to isomerize into
an oﬀ-pathway paused state. Speciﬁcally, we show that
b0F773V and b0SI3 RNAPs, the two fastest variants
among the ones we studied, display pause-free RNA chain
elongation, yet have the same or lower turnover numbers
than does the wild-type enzyme (Figure 5 and data not
shown). Similarly, RfaH fails to accelerate transcription
by the wild-type RNAP on the template devoid of pauses
at saturating NTPs or further enhance elongation by
pause-resistant RNAPs even in the presence of regulatory
pauses. These results are consistent with RfaH and fast
substitutions acting upon the same, ‘pausing’ step.
On the other hand, the slow enzymes fall into two
groups. The ﬁrst group is comprised from the catalytically
competent but pause-prone variants bearing allosterically
acting substitutions (e.g. bQ513P); consistent with its
exclusive eﬀect on pausing, RfaH is able to rescue these
variants. In contrast, two enzymes with substitutions near
the active site (bS1105A, bM1107A) are resistant to the
RfaH-induced acceleration. These residues are located
near the three basic side chains (bR678, bR1106 and
b0R731) that hold the substrate phosphates in the active
site (34)—thus substitutions of bS1105 and bM1107 may
trigger the displacement of the Arg side chains, conse-
quently altering the substrate positioning in the active site
and slowing catalysis. We surmise that RfaH is unable to
correct defects in the active site caused by bS1105A and
bM1107A substitutions which confer diminished catalytic
competence.
RfaHmayfunction by facilitating RNAP translocation
RfaH (or another factor/fast RNAP) may reduce pausing
by (i) stabilizing the pre-translocated state from isomer-
ization into a paused state or (ii) favoring the TEC
transition into the post-translocated state, in which the
Figure 6. RfaH eﬀects on pyrophosphorolysis. (A) TEC may inter-
convert between states in which the 30 end of the nascent RNA
occupies diﬀerent positions in the RNAP active site. (Left) In the
optimal conﬁguration, the 30 OH is in the i site; the i+1 site is ready to
accept the incoming NTP, and the complex is resistant to PPi. (Middle)
In PPi -sensitive complexes, the 30 end occupies the i+1 site, hindering
the NTP binding. (Right) The 30 end of the RNA may become frayed
thereby inhibiting catalysis in both forward and reverse directions;
this rearrangement may accompany isomerization into a short-lived,
elemental pauses and long-lived hairpin-stabilized pauses. (B) Halted
A26 transcription complexes formed in the absence or in the presence
of the N-domain of RfaH were incubated with 25mMP P i at 378C for
the times indicated. The reactions were stopped by the addition of urea
(to 5M) and EDTA (to 30mM) and analyzed on a 12% denaturing gel.
(C) The fraction of the 26-mer full-length RNA was quantiﬁed from the
gels shown in panel B.
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While at least some fast RNAPs (e.g. bP560S,T563I) are
thought to utilize the ﬁrst mechanism (35) (Figure 1),
RfaH likely acts by shifting equilibrium towards the post-
translocated state. Indeed, the RfaH-induced increase in
kcat/Km ratio, and thus presumably the apparent rate of
substrate binding, is a predictable consequence of the
increase in the fraction of post-translocated TEC.
Moreover, we show that RfaH inhibits pyrophospho-
rolysis of the nascent RNA and thus likely facilitates
translocation directly and independently on the substrate
NTP (Figure 6). Interestingly, the RfaH paralog NusG
is also thought to reduce transcriptional pausing by
aﬀecting the TEC translocation; speciﬁcally, by preventing
RNAP backtracking (24,36,37).
TheNTstrandandthebpincerasthetargetsforRfaHaction
We envision at least two mechanisms by which RfaH may
facilitate translocation. First, RfaH directly cross-links to
the NT strand (16) and may act as a ratchet to favor the
forward translocation by binding to the upstream portion
of the NT DNA on the surface of the TEC; such an eﬀect
does not necessarily require a change in the active site
conformation. To evaluate this possibility, we need an
experimental model for the RfaH/NT/RNAP interactions
within the TEC. However, none of the TEC structures
currently available contains the NT DNA strand, and the
only bacterial species for which the high-resolution
structures exist (Thermus) lack RfaH and diﬀer from
E. coli in many RNAP surface features, which are likely
essential for RfaH action.
Second, RfaH may allosterically control the positioning
of RNAP elements that aﬀect its translocation along the
DNA. These elements are yet unknown but several models
that emphasized the key role of the conformational
transitions (bending/straightening) of the bridge helix
(BH) in translocation were proposed (36,38). However,
our structural analysis argued against the BH ﬂexibility
and instead revealed two mobile structural elements, the
b0-subunit trigger loop (TL) and the b-subunit pincer, that
change their positions in the bacterial TECs (34,39).
In the current view of the nucleotide addition cycle
(Figure 7), the TEC translocation between the pre- and
post-states is driven by thermal motions and is biased
toward the post-translocated state by binding of the
incoming NTP substrate in the pre-insertion site. The TL,
which is unstructured in the substrate-free post-
translocated TEC, refolds into two a-helices (trigger
helices, TH) which align with the BH to form the three-
helical bundle in the presence of substrate; this dramatic
structural transition eﬀectively ‘closes’ the active site and
likely represents the rate-limiting step for catalysis (34).
After catalysis and PPi release, the reverse transitions
occur and the active site opens. The TH may unfold upon
PPi release or during translocation. We favor the latter
pathway, in which unfolding occurs in concert with the
b pincer closure, because this scenario is simpler, does not
contradict any data that we are aware of, and readily
explains the formation of the paused state, which occurs
from the pre-translocated state and is accompanied by
the TL folding into an unknown conformation (TL
 ;
Figure 7) likely stabilized by the frayed 30 RNA nt (35).
Accordingly, both structuring (TL!TH) and unstructur-
ing (TL !TL) of the TL may, theoretically, provide an
anti-pausing eﬀect.
Factors that control the TL!TH transition would
be expected to aﬀect both the nucleotide binding (and
NTP-driven translocation) and the formation of the oﬀ-
pathway intermediates. Indeed, deletion of a large b0
domain inserted into the middle of TL in the E. coli
RNAP (in the b0SI3 enzyme) confers catalytic defects
[Figure 5 and (34)] and a pause-resistant, fast phenotype
(Figure 3). Studies in the yeast system also highlighted
the regulatory importance of the TL and suggested that
regulatory proteins may exert their eﬀects through alter-
ing the TL position (40). However, RfaH binds on the
opposite side of the TEC in the model (Figure 3B) and
thus cannot control the TL directly. Allosterically
mediated unfolding of the TL (that would destabilize
both the pre- and paused states) by RfaH cannot be ruled
out oﬀ hand, although we cannot envision a plausible
structural mechanism for this action.
The TEC transition between the open and the closed,
catalytically competent state is also accompanied by
rearrangements of several bulky b domains that trigger
Figure 7. The nucleotide addition cycle (34). The TEC elements shown
are as follows: RNAP (light gray), BH (magenta), RNA (yellow),
NT DNA (black), template DNA (red), TL (cyan) and b pincer
(dark gray). Substrate NTP (blue) in complex with Mg2 binds to the
post-translocated TEC in the pre-insertion site (PS) and then moves to
the active, insertion site (IS); this transition is accompanied by the
active site closure through folding of the TH and opening of the b
pincer. At a pause site, the TL apparently folds into an alternative state
(TL
 ), trapping the frayed 30 nt (35). RfaH may facilitate the b
pincer closure, thereby reducing pausing (paused!post) or favoring the
pre!post transition during the elongation pathway.
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opening (by  4.5A ˚ ) of the downstream DNA channel
(34,39) (Figure 7). We speculate that the b pincer may be
the ultimate target of the RfaH-induced allosteric signal:
RfaH may facilitate the b pincer closure, and thus favor
the TEC transition to the post-translocated state.
Consistently, RfaH interacts with the RNAP domain
(b459–505) (20) that belongs to the group of the
interconnected b domains undergoing systematic struc-
tural rearrangement in the TEC. Interestingly, this b
domain is directly connections to the rifamycin-binding
site, wherein a hypothetical allosteric signal propagated to
the active site originates (29) and in which slow (bQ513P)
and fast (bH526Y) RNAP substitutions are located—
these substitutions can therefore also aﬀect the b pincer
movements. Finally, the stabilization of the b pincer in
a closed conformation may explain the inhibitory eﬀect
of RfaH on the pause-free elongation rate (Figure 5)
that is likely limited by the concerted TH-folding/b
pincer opening (Figure 7). Overall, our results suggest
that RfaH reduces pausing by disfavoring the pause-
forming TEC state. Distinguishing whether RfaH acts
as a ratchet through its contacts to the NT DNA strand,
as an allosteric switch which controls domain rearrange-
ments that accompany transitions between closed and
open RNAP states, or as a combination thereof is not
trivial, and awaits not only the atomic resolution structure
of the RfaH-bound TEC but also a better understanding
of the physicochemical properties of the elemental nucleo-
tide addition cycle of the RNAP.
Fundamental congruity ofantitermination mechanisms
Our analysis revealed many unexpected similarities
between RfaH and lQ, from the mechanism of recruit-
ment to the downstream RNAP modiﬁcation (Figure 8).
Below we compare RfaH and Q mechanisms step by step,
highlighting their similarities and diﬀerences.
Recruitment to the TEC. RfaH is recruited to the
elongating RNAP at ops sequences, which are positioned
100nt or more downstream from a promoter. The ops
element induces RNAP pausing, and likely not only
makes speciﬁc interactions with RfaH but also induces
Figure 8. Comparison of the RfaH and lQ mechanisms. (A) Mechanism of recruitment. (Left) RNAP pauses downstream from the l pR0 promoter
start site (shown by a bent arrow); the pause depends on the s
70 interaction with a –10-like sequence element positioned 12nt downstream from the
promoter –10 hexamer. Q (shown as a dimer) binds to the QBE DNA site located between the –35 and the –10 promoter elements and to the region
4 of the s
70 subunit (47) in the promoter-proximal paused complex. Domain rearrangements in s (likely triggered by the nascent RNA extrusion)
accompany the paused complex formation: s
4 is repositioned relative to s
2, and apparently interacts with the –35-like element adjacent to the pause-
inducing sequence (18). Destabilization of the s
4–b ﬂap interactions unmasks the Q target on core RNAP (22). (Right) RNAP pauses at a promoter-
distal ops site and the N-domain of RfaH binds speciﬁcally to the NT DNA, triggering domain dissociation that in turn unmasks the site on the
N-domain that binds to the b0 CH (20). (B) Post-recruitment TEC modiﬁcation. (Left) Q (likely together with NusA) remains bound to RNAP
throughout transcription of the late l operon making RNAP resistant to pause and all termination signals. (Right) RfaH also remains bound
to RNAP through contacts between the N-domain and the b0 CH (and non-speciﬁc interactions with the NT DNA); RNAP becomes resistant to
pause and some termination signals. The C-domain of RfaH may mediate binding to translation and secretion factors.
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RfaH recruitment (20). In the context of the ops-paused
TEC, the most conserved ops nts are exposed on the TEC
surface in the NT DNA (16). Speciﬁc interactions between
RfaH and the ops DNA delay RNAP downstream from
the ops site (C45 in Figure 2), apparently by inducing
backtracking (G.A.B., unpublished data), and facilitate
dissociation of RfaH domains to unmask the RNAP-
binding site located at the domain interface (20).
Q is recruited to RNAP at the late l promoter. Q binds
to the double-stranded DNA element (QBE) that overlaps
the promoter; however, productive Q recruitment requires
the s initiation factor (18), which interacts with the NT
DNA immediately downstream from the start site to
induce a promoter-proximal pause. s/DNA interaction is
thought to induce a speciﬁc, Q-receptive state of the TEC,
in which partial release of s-promoter and s-core contacts
exposes a target for Q on the core enzyme (22). Speciﬁc
contacts between s and the –10-like element in the NT
DNA also induce RNAP backtracking and thus delay its
escape from the promoter-proximal pause (41).
Thus, in both cases the speciﬁc (but totally diﬀerent)
NT DNA sequence mediates recruitment of antitermina-
tor to RNAP; RfaH recognizes the ops sequence directly,
whereas Q relies on the s factor. Both sets of speciﬁc
contacts must be broken for RNAP escape from the
recruitment site—transient retention of these contacts
induces a characteristic pause. Interactions with the DNA
induce conformational changes in the protein (RfaH or
holoenzyme) that expose the binding site for its partner,
core RNAP or Q, respectively. Finally, the same RNAP
region, the b0 CH, mediates recruitment, either directly,
by binding to RfaH (20), or indirectly, though binding
to s necessary for Q recruitment (42).
Post-recruitment modification. Following the escape from
their respective recruitment sites, RfaH and Q likely lose
all speciﬁc interactions with the nucleic acids but remain
bound to the TEC, essentially turning into the accessory
subunits. The interaction surfaces are likely distinct:
Q may bind to the b ﬂap domain near the nascent RNA
exit channel, whereas RfaH remains bound to the b0CH.
Both proteins, however, apparently induce allosteric
signals that suppresses RNAP pausing. These signals
may converge: the genetic screen for Q-resistant mutants
(43) identiﬁed substitutions near the rifampicin-binding
site and near the active site, the two regions where the
substitutions conferring resistance to RfaH are located;
substitutions of bD675 render RNAP defective in
response to both Q and RfaH. Similarly to RfaH, the
resistance to Q unlikely results from the loss of Q
binding—most of the substituted residues are located in
the interior of the TEC and far apart. This remarkable
convergence in regulatory mechanisms between Q
and RfaH may extend even further, as slow RNAP
variant, bQ513P, was shown to be hypersensitive to
Q-dependent acceleration, while the fast one, bH526Y,
turned out to be resistant, with both enzymes retaining
ability to bind Q (44).
Elongation enhancement versus TEC stabilization. There
is one principal diﬀerence between the action of Q and
RfaH: while both proteins increase the overall elongation
rate, Q (and l N) additionally stabilizes the TEC, thereby
preventing RNA release at terminators. RfaH acts more
as an anti-pausing factor, and is apparently speciﬁc for
those signals that may be particularly sensitive to changes
in the elongation rate. This diﬀerence likely stems from
the distinct regulatory roles of these proteins: unlike the
phage regulators, which ultimately cause cell death, RfaH
modiﬁcation has to be transient and must be turned oﬀ
at the end of the operon. Thus, while RfaH apparently
only reduces pausing (that serves as a prelude to
termination) and does not actively stabilize the complex
against dissociation, other antiterminators apparently
employ additional mechanisms to inhibit RNA release;
the anti-pausing eﬀect alone is insuﬃcient to explain the
dramatic eﬀect of Q (19) and N (45) on termination. The
simplest explanation is that the other contacts
within the TEC, such as that to the nascent RNA (45)
and/or the b ﬂap (22), may directly stabilize the RNA
against the action of terminator hairpins or Rho protein.
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